 Connection
Michele Fox to Antineoplastic Agents
This is a "connection" page, showing publications Michele Fox has written about Antineoplastic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.102 |
|
|
|
-
Barlogie B, Anaissie E, van Rhee F, Haessler J, Hollmig K, Pineda-Roman M, Cottler-Fox M, Mohiuddin A, Alsayed Y, Tricot G, Bolejack V, Zangari M, Epstein J, Petty N, Steward D, Jenkins B, Gurley J, Sullivan E, Crowley J, Shaughnessy JD. Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3. Br J Haematol. 2007 Jul; 138(2):176-85.
Score: 0.087
-
Read EJ, O'Shaughnessy JA, Yu MY, Cottler-Fox M, Denicoff AM, Cowan KH, Gress RE. Flow cytometric quantitation of circulating hematopoietic progenitor cells in breast cancer patients on chemotherapy. Prog Clin Biol Res. 1992; 377:523-30.
Score: 0.007
-
Deeg HJ, Spitzer TR, Cottler-Fox M, Cahill R, Pickle LW. Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis. Bone Marrow Transplant. 1991 Mar; 7(3):193-8.
Score: 0.007
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|